China NT Pharma Group Company Limited (HKG:1011)
Hong Kong
· Delayed Price · Currency is HKD 0.730
0.00 (0.00%)
At close: Mar 10, 2026
HKG:1011 Revenue
China NT Pharma Group Company had revenue of 12.00M CNY in the half year ending June 30, 2025, with 62.84% growth. This brings the company's revenue in the last twelve months to 18.66M, down -3.48% year-over-year. In the year 2024, China NT Pharma Group Company had annual revenue of 37.96M with 415.34% growth.
Revenue (ttm)
18.66M CNY
Revenue Growth
-3.48%
P/S Ratio
24.07
Revenue / Employee
888.48K CNY
Employees
21
Market Cap
492.20M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wai Yuen Tong Medicine Holdings | 721.27M |
| Zhongzhi Pharmaceutical Holdings | 2.20B |
| Pak Fah Yeow International | 199.55M |
| Fusen Pharmaceutical Company | 264.08M |
| Lee's Pharmaceutical Holdings | 1.44B |
| Regent Pacific Group | 6.54M |
| Shenzhen Neptunus Interlong Bio-technique Company | 1.09B |
| Tianda Pharmaceuticals | 310.50M |